Provider Notification – Neighborhood Clinical Medical Policy Procedure Reminder
Notification to providers that Neighborhood's CMP for Urine Toxicology Testing (Screening) #071 will be reviewed by the Clinical Management Committee in July 2021 and reminder of existing coverage rule that immunoassay urine toxicology screening is covered only when performed at point of service; laboratory immunoassay screening is not covered. This notice does not affect definitive/confirmatory laboratory testing.
Reminder that immunoassay urine toxicology screening is covered only when performed at point of service and not covered when performed in a laboratory setting.
Policy summary and purpose
Neighborhood develops and maintains Clinical Medical Policies (CMPs) reviewed annually by the Clinical Management Committee and Medical Director to provide coverage criteria. This notice concerns CMP #071 (Urine Toxicology Testing - Screening) and serves as a provider notification about that CMP. Purpose: to notify providers that CMP #071 will be reviewed in July 2021 and to remind providers of the existing coverage rule for immunoassay urine toxicology screening. Effective: 2021-06-08. Next review: 2021-07-01.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.